Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             207 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A behavioural analysis of self-mutilation Van Moffaert, M.
1992
2 3 p. 216
artikel
2 Acetylcholinesterase in the central and peripheral nervous systems in Alzheimer's disease Appleyard, M.E.
1992
2 3 p. 242-243
artikel
3 A common language in psychiatry Sartorius, N.
1992
2 3 p. 173
artikel
4 A differential influence of typical and atypical neuroleptic drugs on learning and memory in the striatal systems as tested in the Morris Water maze test Scheel-Krüger, J.
1992
2 3 p. 221-223
artikel
5 A double-blind comparison of paroxetine and fluoxetine in the treatment of geriatric patients with major depression Schone, Dr med.
1992
2 3 p. 301
artikel
6 A double blind comparison of paroxetine and loferamine in depressed community patients Moon, C.A.L.
1992
2 3 p. 298
artikel
7 A double-blind comparison o nefazodone and imipramine in the treatment of depressed patients Van Moffaert, M.
1992
2 3 p. 296-297
artikel
8 A double-blind placebo-controlled trial of lithium augmentation in patients showing absent or partial responses to fluoxetine or lofepramine Katona, C.L.E.
1992
2 3 p. 278-279
artikel
9 α-2-Adrenoceptor and μ-opioid receptor densities in the postmortem brain of heroin addicts Garcia-Sevilla, J.A.
1992
2 3 p. 283-284
artikel
10 A follow-up study of tardive dyskinesia in chronic schizophrenics Puca, M.
1992
2 3 p. 341
artikel
11 Age-dependent changes in receptor-mediated and depolarization-induced phosphatidylinositol-turnover in mouse brain Hartmann, H.
1992
2 3 p. 357
artikel
12 Age-related differences in modulation of phosphoinositide metabolism by quisqualic acid in rat cortical slices Michalek, H.
1992
2 3 p. 391
artikel
13 Aggression and depression Ledesma Jimeno, A.
1992
2 3 p. 214-215
artikel
14 A multidimensional pharmacokinetic-biological approach to the neuroleptic treatment of schizophrenias Altamura, A.C.
1992
2 3 p. 236
artikel
15 Another imipramine binding site in human platelets Beltoft, V.
1992
2 3 p. 375-376
artikel
16 Antidepressant-like effects of opioids on learned helplessness model of the depression Gilbert-Rahola, J.
1992
2 3 p. 277-278
artikel
17 Antidepressant response to moclobemide failed to associate with plasma amino acid profiles Møller, S.E.
1992
2 3 p. 299
artikel
18 Antidepressants in the elderly: Factors modifying outcome de la Serna, I.
1992
2 3 p. 302
artikel
19 Anxiolytic effects of drugs acting on 5-HT receptor subtypes Murphy, D.L.
1992
2 3 p. 287-288
artikel
20 Are low doses effective in obsessive compulsive disorder? evidence from placebo-controlled studies Montgomery, S.A.
1992
2 3 p. 199-200
artikel
21 Are serotonin receptors involved in obsessive compulsive disorder? Fineberg, N.
1992
2 3 p. 179-181
artikel
22 Atypical antipsychotics elevate dopamine D3 but not D1 or D2 receptor mRNA levels in rat brain Buckland, P.R.
1992
2 3 p. 348
artikel
23 Atypical neuroleptics clozapine, raclopride and sulpiride decrease striatal in vivo serotonin release in awake rats Bogdanov, M.B.
1992
2 3 p. 349
artikel
24 Automated microcomputerized cognitive evaluation of the elderly and demented: utility, validity, relevance to everyday behaviour and drug sensitivity Wesnes, K.A.
1992
2 3 p. 366
artikel
25 Basic and clinical models for Alzheimer's disease Cutler, N.R.
1992
2 3 p. 238-239
artikel
26 Basic mechanisms of nicotine addiction Stolerman, I.P.
1992
2 3 p. 282-283
artikel
27 Betahistine attenuates learning impairment induced by scopolamine in rats Franco, A.
1992
2 3 p. 354
artikel
28 Brain serotonin, dietary carbohydrates, obesity and depression Wurtman, J.J.
1992
2 3 p. 183-184
artikel
29 Cardiovascular functions during long-term treatment with neuroleptic drugs Jørgensen, E.O.
1992
2 3 p. 344
artikel
30 CCK and dopamine receptors in the brain from rats treated with electroconvulsive therapy Johansen, S.R.
1992
2 3 p. 368
artikel
31 CCK receptor agonists and antagonists in the rodent models of anxiety and drug abuse Harro, J.
1992
2 3 p. 192-193
artikel
32 Central and peripheral interleukin-1 in Alzheimer's disease Alvarez, X.A.
1992
2 3 p. 361-362
artikel
33 Changes in amount of T-lymphocytes of inpatients with alcoholism during long-term treatment course Toomaspoeg, L.
1992
2 3 p. 331-332
artikel
34 Cholecystokinin expression in the central nervous system Rehfeld, J.F.
1992
2 3 p. 189-191
artikel
35 Chronic treatment with antidepressant drugs enhances the excitatory effect of quinpirole on hippocampal neurons in vitro Bijak, M.
1992
2 3 p. 308
artikel
36 Citalopram 20 mg, citalopram 40 mg and placebo in the prevention of relapse of major depression Montgomery, S.A.
1992
2 3 p. 314
artikel
37 Clinical-biological patterns and prediction of response to haloperidol in schizophrenia Altamura, A.C.
1992
2 3 p. 343
artikel
38 Clinical measurement of aggression: a review Bech, P.
1992
2 3 p. 213
artikel
39 Clinical research and evaluation on a low budget Mak, F.L.
1992
2 3 p. 285
artikel
40 Clonidine test in bipolar vs unipolar melancholic patients Pitchot, W.
1992
2 3 p. 306
artikel
41 Clozapine in the treatment of levodopa-induced psychosis Damjanović, A.
1992
2 3 p. 349
artikel
42 Cluster analysis of QEEG/ERP variables as a method for a biologically-based classification system in psychiatry Cancro, R.
1992
2 3 p. 187-188
artikel
43 Co-existent DSM-III-R depression and neurocystcercosis Tavares, A.R.
1992
2 3 p. 290-291
artikel
44 Comorbidity of depression and personality disorders: focus on so-called borderlines Akiskal, H.S.
1992
2 3 p. 207-208
artikel
45 Comorbidity of depression and substance abuse Stefanis, C.N.
1992
2 3 p. 206-207
artikel
46 Comorbidity of panic disorder and depression: a clinical study Bousoño, M.
1992
2 3 p. 317
artikel
47 Comparative sleep laboratory evaluations of quazepam and triazolam in hyposomnic patients with mild to moderate generalized anxiety disorder Saletu, B.
1992
2 3 p. 389
artikel
48 Complications in treatment of paranoid psychosis as a factor of changed reactivity Panasenko, A.I.
1992
2 3 p. 339-340
artikel
49 Consumption of benzodiazepines in heroin addicts admitted for inpatient detoxification between 1982 and 1991 San, L.
1992
2 3 p. 332-333
artikel
50 Correlates of bupropion HCl (Wellbutrin) serum levels with age, weight, sex and cigarette smoking Abuzzahab Sr., F.S.
1992
2 3 p. 303
artikel
51 Correlation between arterial hypertension and depression; therapeutic implications Fodoreanu, L.
1992
2 3 p. 289-290
artikel
52 Correlation between quantitative measures of memory impairment and cerebral vasoreactive capacity assessed by transcranial Doppler in patients with multi-infarct dementia Demarin, V.
1992
2 3 p. 361
artikel
53 Cytokines in cerebellar mutant mice Wollman, E.E.
1992
2 3 p. 265-267
artikel
54 Deficiency of red cell sodium-potassium pump activity in bipolar affective disorder Mikova, O.A.
1992
2 3 p. 305
artikel
55 Depression and panic and other anxiety disorder Cassano, G.B.
1992
2 3 p. 208-210
artikel
56 Depression and panic and other anxiety disorders Cassano, G.B.
1992
2 3 p. 258-260
artikel
57 Depression and serotonin system related disorders: is there a space for serotonin spectrum of disorders? López-Ibor Jr., J.J.
1992
2 3 p. 210-212
artikel
58 Diagnosis and treatment of obsessive-compulsive symptoms in schizophrenia Zohar, J.
1992
2 3 p. 200-201
artikel
59 Diagnosis of Insomnia: Current perspectives Bixler, E.O.
1992
2 3 p. 244-245
artikel
60 Differential involvement of 5-HT in anxiety states Westenberg, H.G.M.
1992
2 3 p. 181-183
artikel
61 Dopamine release in nucleus accumbens in conditioning: microdialysis studies with latent inhibition Young, A.M.J.
1992
2 3 p. 375
artikel
62 Dopaminergic involvement in the action of antidepressant drugs Willner, P.
1992
2 3 p. 224-226
artikel
63 Dose response relationship of citalopram 20 mg, citalopham 40 mg and placebo in the treatment of moderate and severe depression Montgomery, S.A.
1992
2 3 p. 297
artikel
64 Double-blind comparison of fluoxetine and clomipramine in obsessive-compulsive disorder Saiz Ruiz, J.
1992
2 3 p. 204-205
artikel
65 Down syndrome: differentiating mental retardation and dementia Schapiro, M.B.
1992
2 3 p. 239-240
artikel
66 Drug addiction in the light of adaptation and of one natural wish Alferov, V.P.
1992
2 3 p. 335-336
artikel
67 Drug and non-drug treatments of anxiety and insomnia Lader, M.
1992
2 3 p. 260-261
artikel
68 Dysfunctions of peripheral CSN markers in anxiety disorders Marazziti, D.
1992
2 3 p. 315-316
artikel
69 Dysthymia and its treatment: a synthesis López-Ibor Jr., J.J.
1992
2 3 p. 275
artikel
70 Early transcriptional events in the neuroplastic effects of antipsychotics Rogue, P.
1992
2 3 p. 346-347
artikel
71 Effect of CCK agonists and CCK antagonists on morphine withdrawal in the mouse Malinge, M.
1992
2 3 p. 369-370
artikel
72 Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multi-infarct dementia Cacabelos, R.
1992
2 3 p. 362-363
artikel
73 Effect of changes in swimming area on results of ‘behavioral despair test’ Sunal, R.
1992
2 3 p. 310
artikel
74 Effect of fluvoxamine and non-selective antidepressants on cardiovascular reflexes Wilson, S.
1992
2 3 p. 312-313
artikel
75 Effect of imipramine on REM: paradoxical or parallel? Aydin, H.
1992
2 3 p. 389-391
artikel
76 Effect of valproic acid and verapamil on metabolic changes in rat tissues during alcohol withdrawal Pronko, P.S.
1992
2 3 p. 329-330
artikel
77 Effects of alprazolam on metabolic stress-related alterations in HPA axis and catecholamine function in humans Breier, A.
1992
2 3 p. 377
artikel
78 Effects of bretazenil treatment on neutrophil phagocytosis of panic disorder subjects Das, I.
1992
2 3 p. 316
artikel
79 Effects of bromocriptine on striatal dopamine as assessed by brain microdialysis Georgieva, J.
1992
2 3 p. 372
artikel
80 Effects of the free radical scavenger alpha-lipoic acid on memory and NMDA-receptor deficits in aged mice Stoll, S.
1992
2 3 p. 355
artikel
81 Effects of zotepine on the central 5-HT receptor subpopulations Czyrak, A.
1992
2 3 p. 347
artikel
82 Efficacy and safety of benzodiazepines: Mechanisms of action Kales, A.
1992
2 3 p. 246-248
artikel
83 Efficacy of a combined therapy with imipramine and cognitive behavior therapy in the treatment of panic disorder Strauss, W.H.
1992
2 3 p. 318-319
artikel
84 Elevated intracellular calcium levels after 5-HT2 receptor stimulation in platelets of patients with affective disorders Eckert, A.
1992
2 3 p. 291-292
artikel
85 Epidemiological aspects of obsessive-compulsive disorder Osterheider, M.
1992
2 3 p. 382-383
artikel
86 Experimental test therapy in generalized anxiety disorder Wurthmann, C.
1992
2 3 p. 315
artikel
87 Experimental treatment with delta-sleep-inducing peptide (DSIP): Application to chronic insomnia including dependence on hypnotics Schneider-Helmert, D.
1992
2 3 p. 249-250
artikel
88 Flesinoxan, a 5-HT1A agonist, in major depression: Clinical efficacy and effects on rem latency and body temperature (open study) Ansseau, M.
1992
2 3 p. 313
artikel
89 Flumazenil does not antagonize CCK-4 induced panic in healthy volunteers Couetoux du Tertre, A.
1992
2 3 p. 318
artikel
90 Fluvoxamine and maprotiline in chronic neurogenic pain syndromes. Results of a double-blind, crossover study Thoden, U.
1992
2 3 p. 312
artikel
91 Functional investigation in psychiatry using single photon emission tomography with 99mTc-exametazime Goodwin, G.M.
1992
2 3 p. 178-179
artikel
92 Functional relationship between blood-flow velocity in middle cerebral artery and EEG spectral analysis Valle-Inclán, F.
1992
2 3 p. 326
artikel
93 Growth hormone response to apomorphine test in retarded vs agitated depressed patients Pitchot, W.
1992
2 3 p. 307-308
artikel
94 Hematologic side effects of clozapine Hummer, M.
1992
2 3 p. 351-352
artikel
95 Heroin addiction in adult children of alcoholics: biological and clinical effects of fluoxetine Gerra, G.
1992
2 3 p. 334-335
artikel
96 HMPAO-SPECT findings and their relation to psychopathology in schizophrenia and depression Kasper, S.
1992
2 3 p. 323
artikel
97 Hospitalization cost in mood disorders Chinchilla, A.
1992
2 3 p. 293
artikel
98 3H-PK11195 binding to human blood mononuclear cells during the menstrual cycle Ferrero, P.
1992
2 3 p. 378-379
artikel
99 5-HT4 receptors: general pharmacology and control of ionic channels Bockaert, J.
1992
2 3 p. 230-232
artikel
100 Incidence of neuroleptic-induced akathisia Miller, C.H.
1992
2 3 p. 342-343
artikel
101 Induction and assessment of aggression and its biological correlates Netter, P.
1992
2 3 p. 213-214
artikel
102 Influence of amiridine, tacrine and piracetam on passive avoidance conditioning and biochemical indices of gonadectonomized rats Burov, Y.V.
1992
2 3 p. 357-358
artikel
103 Influence of multiple-dose administration of fluvoxamine on the pharmacokinetics of the benzodiazepinen bromazepam and lorazepam: a randomised, cross-over study Van Harten, J.
1992
2 3 p. 381
artikel
104 Interaction of antidepressant drugs (AD) with neuropeptide Y (NPY): a comparative study between imipramine (IMI) and IMAOs Moreno, M.R.
1992
2 3 p. 370-371
artikel
105 Inter- and intracellular communication in CNS Toledano, A.
1992
2 3 p. 254-255
artikel
106 Intracranial self-stimulation affected by methamphetamine as a model of manic episode Takigawa, M.
1992
2 3 p. 352-353
artikel
107 Involvement of interleukin-1β (IL-1β) in cerebral ischaemia LeFeuvre, R.A.
1992
2 3 p. 262-263
artikel
108 Is clozapine induced neutropenia caused by a decreased cytokine release? Sperner-Unterweger, B.
1992
2 3 p. 351
artikel
109 Is the initial improvement a valid criterion for drug choice in acute schizophrenia? Klimke, A.
1992
2 3 p. 337-338
artikel
110 L-365,260, a CKKB receptor antagonist, blocks CCK-4-panic disorder Bradwejn, J.
1992
2 3 p. 378
artikel
111 Lack of red blood cell lipid membrane abnormality in Alzheimer's study Lejoyeux, M.
1992
2 3 p. 358
artikel
112 Longitudinal studies of brain morphology and outcome of schizophrenic disorder Vita, A.
1992
2 3 p. 237
artikel
113 Long-term sertraline treatment of obsessive compulsive disorder: a 52-week double-blind comparative study versus placebo Greist, J.
1992
2 3 p. 386
artikel
114 Low platelet MAO activity in pathological gambling Carrasco, J.L.
1992
2 3 p. 280
artikel
115 L-Tryptophan in obsessive compulsive disorder - a placebo controlled study Montgomery, S.A.
1992
2 3 p. 384-385
artikel
116 Measures of the efficacy of psychotropic drugs in acute treatment: the current status of their validity Maier, W.
1992
2 3 p. 175-176
artikel
117 Mechanisms implicated in the analgesic effect of antidepressant in different nociceptive tests Micó, J.A.
1992
2 3 p. 311
artikel
118 Modelling the memory impairment of Alzheimer's disease: the use of pharmacological probes in humans Sunderland, T.
1992
2 3 p. 241-242
artikel
119 Molecular cloning, pharmacological characterization and genetic studies of the human dopamine transporter Giros, B.
1992
2 3 p. 268-269
artikel
120 Multicenter trial of flupenthixol-decanoat in different dose regimens for relapse prevention Osterheider, M.
1992
2 3 p. 342
artikel
121 Multimodality evoked potentials in family-history positive and family-history negative alcoholics Grau, C.
1992
2 3 p. 327
artikel
122 Naltrexone maintenance programs for heroin addicts: retention rates in Vitoria (Spain) Ballesteros, J.
1992
2 3 p. 333
artikel
123 Nefazodone vs amitriptyline in major depressive inpatients Ansseau, M.
1992
2 3 p. 295
artikel
124 Neuroendocrine responses to intravenous flesinoxan as an index of serotonergic neurotransmission Ansseau, M.
1992
2 3 p. 376
artikel
125 Neuroendocrine studies in dementia patients. Responses of plasma PRL and GH following bromocriptine administration Higashi, S.
1992
2 3 p. 363-364
artikel
126 Neuroleptics plus benzodiazepines in schizophrenia Chinchilla, A.
1992
2 3 p. 344
artikel
127 Neuropeptides in rat brain: modification by lithium and electroconvulsive treatment Mathé, A.A.
1992
2 3 p. 367-368
artikel
128 Neurotransmitter transporter mechanisms: therapeutic implications Ackenheil, M.
1992
2 3 p. 273
artikel
129 Never treated schizophrenics do present tardive dyskinesia-like abnormal movements Moussaoui, D.
1992
2 3 p. 339
artikel
130 Newer Hypnotic Drugs Vela-Bueno, A.
1992
2 3 p. 248-249
artikel
131 Non-pharmacologic treatment of insomnia Soldatos, C.R.
1992
2 3 p. 251-252
artikel
132 Novel treatment strategies in schizophrenia Rogue, Patrick
1992
2 3 p. 337
artikel
133 Obsessive compulsive disorder: update in treatment possibilities Chinchilla, A.
1992
2 3 p. 384
artikel
134 OCD floats free of anxiety Montgomery, S.A.
1992
2 3 p. 217-218
artikel
135 Onset of improvement under antidepressant treatment: a survival analytical approach Stassen, H.H.
1992
2 3 p. 319
artikel
136 On the clinical experience and pharmacology of presynaptic dopamine receptor agonists Martenyi, F.
1992
2 3 p. 345
artikel
137 On the role of serotonin in learning and memory McEntee, W.J.
1992
2 3 p. 184-185
artikel
138 Ontogeny of 5HT2 receptor gene expression in developing rat brain Ciaranello, R.D.
1992
2 3 p. 286
artikel
139 Open trial of clomipramine versus fluoxetine versus no-treatment in obsessive-compulsive volunteers Ravizza, L.
1992
2 3 p. 385-386
artikel
140 Opioid peptide receptor blockade in the treatment of schizophrenia Marchesi, G.F.
1992
2 3 p. 365-366
artikel
141 Optimized carbamazepine dosing in alcohol withdrawal Grüner, J.F.
1992
2 3 p. 330-331
artikel
142 Parieto-temporal hypoperfusion in Alzheimer's disease measured by transcranial-doppler ultrasonography Caamaño, J.
1992
2 3 p. 360
artikel
143 Peripheral CNS markers in OCD Marazziti, D.
1992
2 3 p. 202-203
artikel
144 Personality patterns, comorbidity and spectrum disorders in primary OCD Osterheider, M.
1992
2 3 p. 383
artikel
145 PET scanning: understanding Alzheimer's disease Mazziota, J.C.
1992
2 3 p. 241
artikel
146 Pharmaco-EEG profile of intravenous zolpidem in healthy volunteers Pata, A.
1992
2 3 p. 387-388
artikel
147 Pharmacological treatment of chronic insomnia due to psychiatric cause Estivill, E.
1992
2 3 p. 320
artikel
148 Pharmacology of cholecystokinin agonists and antagonists Bourin, M.
1992
2 3 p. 196-198
artikel
149 Pharmacopsychological properties of DAU 6215 CL, a 5 HT3-antagonist, in phase 1 anhedonia and anxiety performance models Leonard, J.P.
1992
2 3 p. 379
artikel
150 Phase I study of single ascending doses of befloxatone, a new reversible MAO-A inhibitor antidepressant Ansseau, M.
1992
2 3 p. 300
artikel
151 P300 in patients with panic disorder with and without agoraphobia Schmitz, F.
1992
2 3 p. 327-328
artikel
152 Plasma levels of amitriptyline after a single dose - a predictor for treatment response? Stuppäck, C.H.
1992
2 3 p. 304
artikel
153 Platelet paroxetine binding in alcoholics Mellerup, E.T.
1992
2 3 p. 329
artikel
154 Possible cholinergic mechanism behind the galanin evoked acetylcholine release in the rat striatum Pramanik, A.
1992
2 3 p. 374
artikel
155 Post-stroke depression: a neuroimaging study Pozzilli, C.
1992
2 3 p. 321
artikel
156 Prediction of the evalution of cognitive deterioration in the elderly using QEEG Prichep, L.S.
1992
2 3 p. 186
artikel
157 Prediction of the response to treatment in OCD and panic disorder patients using cluster analysis of QEEG variables Mas, F.
1992
2 3 p. 186
artikel
158 Predictive value of a single-dose test of antidepressant drugs on sleep-EEG endogenous depressive pattern Pringuey, D.
1992
2 3 p. 294-295
artikel
159 Predictors for longterm use of benzodiazepines Whitworth, A.B.
1992
2 3 p. 380-381
artikel
160 Prevalence and treatments of sleep disorders in elderly people living in Oviedo, Spain Bobes-Garcia, J.
1992
2 3 p. 387
artikel
161 Problem of the neuroleptical treatment in the elderly; some observations on dose-related side effects Ravizza, L.
1992
2 3 p. 364
artikel
162 Prolactin and thyrotropin secretion during ECT Papadimitriou, G.N.
1992
2 3 p. 309
artikel
163 Prospective evaluation of the ‘Serotonin Syndrome’ in depressed patients treated with clomipramine Lejoyeux, M.
1992
2 3 p. 300-301
artikel
164 Protective effects of imipramine maintenance in panic disorder with agoraphobia Mavissakalian, M.
1992
2 3 p. 380
artikel
165 Psychological functions of forebrain serotonin: evidence from animal studies Everitt, B.J.
1992
2 3 p. 177-178
artikel
166 Psychosensorial rest and cognitive EEG mapping (EEGM): a study of acute and remission schizophrenics treated with neuroleptics (NL) Marchesi, G.F.
1992
2 3 p. 324-325
artikel
167 QEEG/ERP and PET 2-DG profiles of 5 subtypes of schizophrenic patients John, E.R.
1992
2 3 p. 187
artikel
168 Red blood cell folate and suicidal behavior Pitchot, W.
1992
2 3 p. 306-307
artikel
169 Relationship between clonidine test and suicidal behavior Pitchot, W.
1992
2 3 p. 307
artikel
170 Relevance of drug discrimination methods for the evaluation of antipsychotic drugs Arnt, J.
1992
2 3 p. 223-224
artikel
171 Resistant schizophrenia: Therapeutical alternatives Chinchilla, A.
1992
2 3 p. 338
artikel
172 Responses of plasma prolactin and GH after sulpiride loading on the patients with organic dementia Nishimoto, Y.
1992
2 3 p. 359
artikel
173 Rising-dose fluvoxamine therapy in depression; an overview of two clinical studies Deerling, R.
1992
2 3 p. 302-303
artikel
174 Risks of longterm treatment with cholinesterase inhibitors in age-related memory deficits - model study in old rats Benesová, O.
1992
2 3 p. 356
artikel
175 Seasonal allergic rhinitis and antihistamine effects on children's learning Vuurman, E.
1992
2 3 p. 263-265
artikel
176 Serotonin and control of impulses in drug dependence Perez de los Cobos, J.C.
1992
2 3 p. 281-282
artikel
177 Serotonin antagonists as antipsychotic drugs Nemeroff, C.B.
1992
2 3 p. 287
artikel
178 Serum histamine in Alzheimer's disease and multi-infarct dementia Fernández-Novoa, L.
1992
2 3 p. 360
artikel
179 Sexual selection, ‘machiavellian’ intelligence and the origins of psychosis Crow, T.J.
1992
2 3 p. 255-257
artikel
180 Side-effects and efficacy of clozapine in the treatment of acute schizophrenia Klimke, A.
1992
2 3 p. 350
artikel
181 Single positron emission tomography (SPECT) correlates of cognitive and behavioral dysfunction in Alzheimer's disease Schmitt, F.A.
1992
2 3 p. 322
artikel
182 Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists Rogóż, Z.
1992
2 3 p. 373
artikel
183 SPECT imaging of D2 receptors in depression D'Haenen, H.
1992
2 3 p. 324
artikel
184 Spiperone-labelled dopamine transporter in lymphocytes Bondy, B.
1992
2 3 p. 269-270
artikel
185 Structure and function of the serotonin transporter Graham, D.
1992
2 3 p. 271-272
artikel
186 Structure-function correlation of muscarinic acetylfholine receptors Lai, J.
1992
2 3 p. 227-228
artikel
187 Subtypes of alpha-1 and alpha-2 adrenergic receptors Bylund, D.B.
1992
2 3 p. 229-230
artikel
188 The anxiogenic effects of CCK-4 in monkeys are reduced by CCK-B antagonists, benzodiazepines or adenosine A2 agonists Palmour, R.M.
1992
2 3 p. 193-195
artikel
189 The effects of lithium and carbamazepine on selected immunological indices in affective patients Rybakowski, J.
1992
2 3 p. 304-305
artikel
190 The influences of sulpiride (D2 receptor blockade) on P300 Sakao, M.
1992
2 3 p. 326-327
artikel
191 The involvement of endorphins and dopamine in experimental addiction van Ree, J.M.
1992
2 3 p. 219-221
artikel
192 The neuropathology of schizophrenia. Limbic system, brain development and cerebral dominance Falkai, P.
1992
2 3 p. 235
artikel
193 Therapeutic effects of citalopram in psychotic patients Syvälahti, E.K.G.
1992
2 3 p. 340-341
artikel
194 The Raphe nuclei as a preferential target for antidepressant drugs acting on the 5-HT system: in vivo microdialysis studies in freely-moving rats Artigas, F.
1992
2 3 p. 276-277
artikel
195 The rewarding properties of alcohol are attenuated by 5-HT3 receptor blockade Johnson, B.A.
1992
2 3 p. 284
artikel
196 The role of CCK receptors in panic disorders: clinical studies Bradwejn, J.
1992
2 3 p. 195-196
artikel
197 The role of phospholipase-A2(PLA-2) enzyme in the etiology of depression Çetin, M.
1992
2 3 p. 291
artikel
198 The selectivity of zolpidem and alpidem for the α 1-subunit of the GABAA receptor Langer, S.Z.
1992
2 3 p. 232-234
artikel
199 The use of dissociation kinetic in studying receptor structure and function Errebo, I.
1992
2 3 p. 310-311
artikel
200 The world psychiatric association presidential educational programs Costa, e Silva J.A.
1992
2 3 p. 174
artikel
201 Trazodone in benzodiazepine dependence Ansseau, M.
1992
2 3 p. 382
artikel
202 Tyrosine metabolism in oral contraceptive users: evidence for contribution to depression Møller, S.E.
1992
2 3 p. 292-293
artikel
203 Use of immunohistochemical and statistical approach for a cholecystokinin-binding protein study of hippocampal cell cultures Rudenko, O.A.
1992
2 3 p. 368-369
artikel
204 V.A. Kral and senescent forgetfulness: an affair to remember Berrios, G.E.
1992
2 3 p. 253
artikel
205 Weight gain: a frequent side-effect of clozapine treatment Kurz, M.
1992
2 3 p. 350
artikel
206 World psychiatric association task force on sedative hypnotics: Part I Visotsky, H.M.
1992
2 3 p. 285
artikel
207 Zopiclone: a new treatment for insomnia Chinchilla, A.
1992
2 3 p. 388
artikel
                             207 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland